These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1866054)

  • 1. Biocompatibility of haemodialysis systems: present and future. Vienna, 9 September 1990.
    Nephrol Dial Transplant; 1991; 6 Suppl 2():1-126. PubMed ID: 1866054
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in the biocompatibility of haemodialysis membranes.
    Schulman G; Hakim RM
    Nephrol Dial Transplant; 1991; 6 Suppl 2():10-3. PubMed ID: 1866056
    [No Abstract]   [Full Text] [Related]  

  • 3. [Twenty years of research in the field of haemodialysis: the contribution of the Nephrology Department of Erasme Hospital].
    Tielemans C
    Rev Med Brux; 2008; 29(1 Suppl):S15-8. PubMed ID: 18497215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term evaluation of the biocompatibility of nine different haemodialysis membranes.
    Forêt M; Hachache T; Meftahi H; Milongo R; Kuentz F; Christollet M; Alibeu C; Cordonnier DJ
    Life Support Syst; 1987; 5(3):203-6. PubMed ID: 3695581
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in the biocompatibility of haemodialysis membranes.
    Hakim RM
    Nephrol Dial Transplant; 1995; 10 Suppl 10():7-11. PubMed ID: 8825426
    [No Abstract]   [Full Text] [Related]  

  • 6. Biocompatibility and capability of haemopurification systems: review and future development.
    Ota K
    Nephrol Dial Transplant; 1991; 6 Suppl 2():86-90. PubMed ID: 1866077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of haemodialysis on coagulation and platelets: are we measuring membrane biocompatibility?
    Ward RA
    Nephrol Dial Transplant; 1995; 10 Suppl 10():12-17. PubMed ID: 8825427
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum angiotensin-converting enzyme during haemodialysis: effect of membrane biocompatibility.
    Maher ER; Bird R; Kyle P; Curtis JR
    Nephron; 1987; 45(4):328. PubMed ID: 3035394
    [No Abstract]   [Full Text] [Related]  

  • 9. Adequacy, nutrition, and biocompatibility: their relevance on clinical outcome in haemodialysis patients.
    Movilli E
    Blood Purif; 1999; 17(2-3):159-65. PubMed ID: 10449874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
    Szepietowski T; Krajewska M
    Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility and risk of infection in haemodialysis patients.
    Himmelfarb J; Hakim RM
    Nephrol Dial Transplant; 1994; 9 Suppl 2():138-44. PubMed ID: 8065605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatibility: is it a relevant consideration for today's haemodialysis?
    Shaldon S; Vienken J
    Int J Artif Organs; 1996 Apr; 19(4):201-14. PubMed ID: 8786170
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostacyclin and heparin during haemodialysis: comparative effects.
    Camici M; Evangelisti L
    Life Support Syst; 1986; 4(3):205-9. PubMed ID: 3537544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatibility of dialysis membranes: a comparative study.
    Martin-Malo A; Castillo D; Castro M; Pérez R; Rios A; Jaraba M; Aljama P
    Nephrol Dial Transplant; 1991; 6 Suppl 2():55-8. PubMed ID: 1866069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: membranes for haemodialysis.
    Kerr PG; Huang L
    Nephrology (Carlton); 2010 Jun; 15(4):381-5. PubMed ID: 20609086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets].
    Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I
    Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
    Szepietowski T; el-Hayek A
    Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.
    Krieter DH; Lemke HD; Wanner C
    Nephrol Dial Transplant; 2006 Feb; 21(2):546; author reply 546. PubMed ID: 16249195
    [No Abstract]   [Full Text] [Related]  

  • 19. Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations.
    Pieroni L; Levi Mortera S; Greco V; Sirolli V; Ronci M; Felaco P; Fucci G; De Fulviis S; Massoud R; Condò S; Capria A; Di Daniele N; Bernardini S; Urbani A; Bonomini M
    Mol Biosyst; 2015 Jun; 11(6):1633-43. PubMed ID: 25845767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis membrane biocompatibility and mortality and morbidity in acute renal failure.
    Himmelfarb J; Hakim RM
    J Nephrol; 1997; 10(2):63-4. PubMed ID: 9238611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.